Business, energy, technology, markets and global industry news from Business News Today

hypertension

PharmaDeviceNews hypertension
Representative image: A cuffless fingertip blood pressure monitoring device shows how Biozen’s FDA-cleared BP1000 could make calibration-free hypertension checks more accessible for home care and remote patient monitoring.
Medical Devices & Diagnostics

Can Biozen turn cuffless blood pressure from medtech promise into clinical reality?

Cuffs are accurate but inconvenient. Biozen’s FDA-cleared BP1000 tests whether fingertip blood pressure checks can change hypertension care.

Read More
Medical Devices & Diagnostics

What Orchestra BioMed Holdings, Inc.’s AVIM strategy reveals about the future of hypertension device innovation

FDA backing boosts AVIM therapy momentum. Discover how Orchestra BioMed Holdings, Inc. is shaping the future of hypertension treatment.

Read More
Pharma & Biotech

How Alnylam Pharmaceuticals is using new ACC.26 data to deepen the case for vutrisiran and zilebesiran

See why Alnylam Pharmaceuticals’ new ACC.26 data on vutrisiran and zilebesiran could reshape cardiovascular strategy and market expectations.

Read More
Biobeat’s ABPM device gets backing from Ally Bridge, OrbiMed, Elevage in $50M Series B
Medical Devices & Diagnostics

Will Biobeat’s wearable BP patch become the new standard in hypertension diagnosis?

Biobeat raises $50M to commercialize its FDA-cleared patch-worn ABPM system. Find out how this device could change hypertension care in the U.S.

Read More